Duke University Health System

Summary

Duke University Health System is a medical facility located in Raleigh, North Carolina. This center is recognized for care of Brain Tumor, Lung Cancer, Glioblastoma, Gliosarcoma, Non-Small Cell Lung Cancer and other specialties. Duke University Health System is involved with conducting 198 clinical trials across 541 conditions. There are 25 research doctors associated with this hospital, such as Jeffrey Crawford, Angeles A. Secord, Harry P. Erba, and Cristina Gasparetto, MD.

Top PIs

Clinical Trials running at Duke University Health System

Brain Tumor

Lung Cancer

Diffuse Intrinsic Pontine Glioma

Scoliosis

Glioblastoma

Melanoma

Bladder Cancer

Kyphosis

Spinal Cord Injury

Cutaneous Melanoma

ACTEMRA

for Pediatric Craniopharyngioma

This trial tests ACTEMRA, a drug that blocks a protein called IL-6, in children with a recurring brain tumor called ACP. The goal is to see if it can reduce tumor growth and improve their quality of life.

Recruiting

1 award

Phase 2

35 criteria

Larotrectinib

for Brain Cancer

This is a pilot study that will evaluate disease status in children that have been newly diagnosed high-grade glioma with TRK fusion. The evaluation will occur after 2 cycles of the medication (Larotrectinib) have been given. The study will also evaluate the safety of larotrectinib when given with chemotherapy in your children; as well as the safety larotrectinib when given post-focal radiation therapy.

Recruiting

1 award

Phase < 1

11 criteria

Lutathera

for Brain Tumor

This trial tests Lutathera, a radioactive drug given through an IV, in patients with certain brain tumors that haven't responded to other treatments. The drug attaches to cancer cells and uses radiation to kill them.

Recruiting

1 award

Phase 1 & 2

20 criteria